A novel diterpenequinone named salvicine (4), structurally modified derivat
ive of a natural product, and a series of the novel analogs have been prepa
red. Most of the analogs were found to be potently active against tumor cel
l lines in vitro. Further study on 4 in vivo demonstrated that it possessed
a significant antineoplastic activity against murine S-180 Sarcoma and Lew
is lung cancer, and human lung adenocarcinoma xenografts A-549 and LAX-83.
The preclinical studies of 4 are now under way. (C) 1999 Elsevier Science L
td. All rights reserved.